Phenylethylmalonamide in essential tremor. A double-blind controlled study.

A randomised double-blind placebo-controlled trial of phenylethylmalonamide, the major metabolite of primidone was performed in eight patients with essential tremor. Phenylethylmalonamide was given in a daily dose of 400 mg for one week and 800 mg for a second week. The compound had no statistically...

Celý popis

Podrobná bibliografie

Vydáno v:	J Neurol Neurosurg Psychiatry
Hlavní autoři:	Calzetti, S, Findley, L J, Pisani, F, Richens, A
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMJ Publishing Group 1981
Témata:	Research Article
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC491180/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7031184/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jnnp.44.10.932
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!